October 16, 2008
The Medicare Part D insurance plan may be wasting billions of dollars on intravenous drug treatments. Because it does not cover many of the drug-related costs of home-care treatment, patients have to go to the hospital, where Medicare ends up spending a lot more, according to a recent Wall Street Journal article.